Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil.

Palmero EI, Caleffi M, Schüler-Faccini L, Roth FL, Kalakun L, Netto CB, Skonieski G, Giacomazzi J, Weber B, Giugliani R, Camey SA, Ashton-Prolla P.

Genet Mol Biol. 2009 Jul;32(3):447-55. doi: 10.1590/S1415-47572009005000058. Epub 2009 Sep 1.

2.

Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.

Palmero EI, Alemar B, Schüler-Faccini L, Hainaut P, Moreira-Filho CA, Ewald IP, Santos PK, Ribeiro PL, Oliveira CB, Calvez-Kelm FL, Tavtigian S, Cossio SL, Giugliani R, Caleffi M, Ashton-Prolla P.

Genet Mol Biol. 2016 May 24;39(2):210-22. doi: 10.1590/1678-4685-GMB-2014-0363. Erratum in: Genet Mol Biol. 2017 Mar 16;:0.

4.

Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.

Mai PL, Lagos VI, Palomares MR, Weitzel JN.

Ann Surg Oncol. 2008 Dec;15(12):3415-21. doi: 10.1245/s10434-008-0160-3. Epub 2008 Oct 4.

5.

A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).

Caleffi M, Ribeiro RA, Duarte Filho DL, Ashton-Prolla P, Bedin AJ Jr, Skonieski GP, Zignani JM, Giacomazzi J, Franco LR, Graudenz M, Pohlmann P, Fernandes JG, Kivitz P, Weber B.

BMC Public Health. 2009 Mar 13;9:83. doi: 10.1186/1471-2458-9-83.

6.

Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.

Giacomazzi CR, Giacomazzi J, Netto CB, Santos-Silva P, Selistre SG, Maia AL, Oliveira VZ, Camey SA, Goldim JR, Ashton-Prolla P.

Rev Assoc Med Bras (1992). 2015 May-Jun;61(3):282-9. doi: 10.1590/1806-9282.61.03.282. Review.

7.

Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.

Palmero EI, Schüler-Faccini L, Caleffi M, Achatz MI, Olivier M, Martel-Planche G, Marcel V, Aguiar E, Giacomazzi J, Ewald IP, Giugliani R, Hainaut P, Ashton-Prolla P.

Cancer Lett. 2008 Mar 8;261(1):21-5. doi: 10.1016/j.canlet.2007.10.044. Epub 2008 Jan 11.

PMID:
18248785
8.

Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer.

Lagos VI, Perez MA, Ricker CN, Blazer KR, Santiago NM, Feldman N, Viveros L, Weitzel JN.

Psychooncology. 2008 Aug;17(8):774-82. doi: 10.1002/pon.1358.

PMID:
18646245
9.

Provider's Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer.

Hurtado-de-Mendoza A, Graves K, Gómez-Trillos S, Anderson L, Campos C, Evans C, Stearns S, Zhu Q, Gonzalez N, Sheppard VB.

Healthcare (Basel). 2018 Sep 17;6(3). pii: E116. doi: 10.3390/healthcare6030116.

10.

The prevalence of hereditary breast/ovarian cancer risk in patients with a history of breast or ovarian cancer in Japanese subjects.

Komata D, Yahata T, Kodama S, Koyama Y, Takeda N, Tajima K, Makino H, Sato N, Muto I, Hatakeyama K, Tanaka K.

J Obstet Gynaecol Res. 2009 Oct;35(5):912-7. doi: 10.1111/j.1447-0756.2009.01090.x.

PMID:
20149041
11.

Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.

Giacomazzi J, Selistre SG, Rossi C, Alemar B, Santos-Silva P, Pereira FS, Netto CB, Cossio SL, Roth DE, Brunetto AL, Zagonel-Oliveira M, Martel-Planche G, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P.

Cancer. 2013 Dec 15;119(24):4341-9. doi: 10.1002/cncr.28346. Epub 2013 Oct 7.

12.

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.

Ashton-Prolla P, Giacomazzi J, Schmidt AV, Roth FL, Palmero EI, Kalakun L, Aguiar ES, Moreira SM, Batassini E, Belo-Reyes V, Schuler-Faccini L, Giugliani R, Caleffi M, Camey SA.

BMC Cancer. 2009 Aug 14;9:283. doi: 10.1186/1471-2407-9-283.

14.

Identification of familial clustering for cancer through the family health strategy program in the municipality of Angra dos Reis, Rio de Janeiro, Brazil.

Vieira DK, Attianezi M, Esposito AC, Barth A, Sequeira C, Krause N, Oliveira V, Lucidi A, Serao C, Llerena JC Jr.

J Community Genet. 2015 Jan;6(1):9-16. doi: 10.1007/s12687-014-0196-y. Epub 2014 Jul 26.

15.

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.

Mouchawar J, Korch C, Byers T, Pitts TM, Li E, McCredie MR, Giles GG, Hopper JL, Southey MC.

Cancer Res. 2010 Jun 15;70(12):4795-800. doi: 10.1158/0008-5472.CAN-09-0851. Epub 2010 May 25.

16.

Breast cancer mortality among Ashkenazi Jewish women in São Paulo and Porto Alegre, Brazil.

Koifman S, Jorge Koifman R.

Breast Cancer Res. 2001;3(4):270-5. Epub 2001 May 9.

17.

Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.

Hughes KS, Roche C, Campbell CT, Siegel N, Salisbury L, Chekos A, Katz MS, Edell E.

Breast J. 2003 Jan-Feb;9(1):19-25.

PMID:
12558666
18.

Committee opinion no. 634: Hereditary cancer syndromes and risk assessment.

[No authors listed]

Obstet Gynecol. 2015 Jun;125(6):1538-43. doi: 10.1097/01.AOG.0000466373.71146.51.

PMID:
26000542
19.

Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.

Lynch HT, Silva E, Snyder C, Lynch JF.

Breast J. 2008 Jan-Feb;14(1):3-13. Epub 2007 Dec 11. Review.

PMID:
18086272
20.

Germline TP53 mutational spectrum in French Canadians with breast cancer.

Arcand SL, Akbari MR, Mes-Masson AM, Provencher D, Foulkes WD, Narod SA, Tonin PN.

BMC Med Genet. 2015 Apr 12;16:24. doi: 10.1186/s12881-015-0169-y.

Supplemental Content

Support Center